Transcather aortic valve implantation (TAVI) has become a safe and indispensable treatment option for patients with severe symptomatic aortic stenosis who are at high surgical risk. Recently, outcomes after TAVI have improved significantly and TAVI has emerged as a qualified alternative to surgical aortic valve replacement in the treatment of intermediate risk patients and greater adoption of this procedure is to be expected in a wider patients population, including younger patients and low surgical risk patients. However since the aortic valve has close spatial proximity to the conduction system, conduction anomalies are frequently observed in TAVI. In this article, we aim to review the key aspects of pathophysiology, current incidence, predictors and clinical association of conduction anomalies following TAVI.
Russo E, Potenza DR, Casella M, Massaro R, Russo G, Braccio M, Russo AD, Cassese M. Rate and Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation: Current Status. Curr Cardiol Rev 2018 Dec 4. doi: 10.2174/1573403X15666181205105821. [Epub ahead of print]